SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001157523-11-005370
Filing Date
2011-09-13
Accepted
2011-09-13 08:32:45
Documents
21
Period of Report
2011-09-13
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 OPEXA THERAPEUTICS, INC. 8-K a6858248.htm 8-K 29632
2 EXHIBIT 99.1 a6858248ex99_1.htm EX-99.1 34446
3 SLIDE 1 slide1.jpg GRAPHIC 45547
4 SLIDE 2 slide2.jpg GRAPHIC 158391
5 SLIDE 3 slide3.jpg GRAPHIC 84310
6 SLIDE 4 slide4.jpg GRAPHIC 72288
7 SLIDE 5 slide5.jpg GRAPHIC 88996
8 SLIDE 6 slide6.jpg GRAPHIC 52199
9 SLIDE 7 slide7.jpg GRAPHIC 87432
10 SLIDE 8 slide8.jpg GRAPHIC 96925
11 SLIDE 9 slide9.jpg GRAPHIC 48781
12 SLIDE 10 slide10.jpg GRAPHIC 55733
13 SLIDE 11 slide11.jpg GRAPHIC 52139
14 SLIDE 12 slide12.jpg GRAPHIC 61044
15 SLIDE 13 slide13.jpg GRAPHIC 70334
16 SLIDE 14 slide14.jpg GRAPHIC 60229
17 SLIDE 15 slide15.jpg GRAPHIC 67549
18 SLIDE 16 slide16.jpg GRAPHIC 67544
19 SLIDE 17 slide17.jpg GRAPHIC 98058
20 SLIDE 18 slide18.jpg GRAPHIC 50731
21 SLIDE 19 slide19.jpg GRAPHIC 50878
  Complete submission text file 0001157523-11-005370.txt   1954422
Mailing Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381
Business Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381 (281) 272-9331
Opexa Therapeutics, Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 760333165 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33004 | Film No.: 111086911
SIC: 2834 Pharmaceutical Preparations